Showing results (281-290 of 640) with videos related to
Sort By:
Pageof 64
Postgraduate Medicine|October 12, 2013
Prostate cancer and the increasing role of active surveillanceDavid Gabriel Alonzo, Amanda Lynne Mure, Mark S SolowayUrology|March 1, 1985
Effect of concentration and time of drug exposure on clonal growth of murine bladder cancerH B Niell, M S Soloway, C A WoodClinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1997
Prostate-specific membrane antigen expression in normal and malignant human tissuesD A Silver, I Pellicer, W R Fair, et al.Cancer Research|October 11, 1991
Molecular genetic alterations in superficial and locally advanced human bladder cancerJ C Presti, V E Reuter, T Galan, et al.The Prostate|January 1, 1992
Prognostic significance of antigenic heterogeneity, Gleason grade, and ploidy of lymph node metastases in patients with prostate cancerM Bazinet, S M Hamdy, L R Bégin, et al.Urology|October 1, 1994
Changes in immunohistochemical staining of PSA, PAP, and TURP-27 following irradiation therapy for clinically localized prostate cancerB M Grob, P F Schellhammer, D N Brassil, et al.The Journal of Urology|January 1, 1988
Free radical production by high energy shock waves--comparison with ionizing irradiationT R Morgan, V P Laudone, W D Heston, et al.Prostate Cancer and Prostatic Diseases|December 7, 2011
Active surveillance for low-risk prostate cancer: knowledge, acceptance and practice among urologistsM A Gorin, A Eldefrawy, O Ekwenna, et al.The Journal of Urology|March 20, 2012
Clinical and demographic characteristics associated with prostate cancer progression in patients on active surveillanceViacheslav Iremashvili, Mark S Soloway, Daniel L Rosenberg, et al.National Cancer Institute Monograph|December 1, 1978
Immunogenicity of N-[-4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced bladder cancerM S Soloway, C Martino, C Hyatt, et al.Pageof 64